NASDAQ:KIDS - Orthopediatrics Stock Price, Price Target & More

$19.70 -0.96 (-4.65 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$20.66
Today's Range$19.70 - $20.60
52-Week Range$14.00 - $23.00
Volume40,620 shs
Average Volume49,263 shs
Market Capitalization$257.46 million
P/E Ratio-3.62
Dividend YieldN/A
BetaN/A

About Orthopediatrics (NASDAQ:KIDS)

Orthopediatrics logoOrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Debt-to-Equity Ratio0.53%
Current Ratio7.35%
Quick Ratio5.29%

Price-To-Earnings

Trailing P/E Ratio-3.62
Forward P/E Ratio-29.85
P/E GrowthN/A

Sales & Book Value

Annual Sales$45.62 million
Price / Sales5.51
Cash FlowN/A
Price / CashN/A
Book Value$3.74 per share
Price / Book5.27

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees69
Outstanding Shares12,770,000

How to Become a New Pot Stock Millionaire

Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) released its earnings results on Wednesday, March, 7th. The company reported ($3.93) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $3.80. The firm earned $11.68 million during the quarter, compared to analysts' expectations of $11.45 million. View Orthopediatrics' Earnings History.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, June, 6th 2018. View Earnings Estimates for Orthopediatrics.

What price target have analysts set for KIDS?

4 brokers have issued 1 year target prices for Orthopediatrics' stock. Their forecasts range from $23.00 to $24.00. On average, they expect Orthopediatrics' stock price to reach $23.6667 in the next twelve months. View Analyst Ratings for Orthopediatrics.

Who are some of Orthopediatrics' key competitors?

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the folowing people:
  • Mr. Mark C. Throdahl, CEO, Pres & Director (Age 67)
  • Mr. Fred L. Hite, CFO & Director (Age 50)
  • Mr. David R. Bailey, Exec. VP (Age 39)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 48)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 48)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

When did Orthopediatrics' lock-up period expire?

Orthopediatrics' lock-up period expired on Tuesday, April 10th. Orthopediatrics had issued 4,000,000 shares in its public offering on October 12th. The total size of the offering was $52,000,000 based on an initial share price of $13.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Has Orthopediatrics been receiving favorable news coverage?

News stories about KIDS stock have been trending somewhat positive on Friday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Orthopediatrics earned a news sentiment score of 0.22 on Accern's scale. They also assigned press coverage about the company an impact score of 46.94 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $19.70.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $257.46 million and generates $45.62 million in revenue each year. The company earns $-8,930,000.00 in net income (profit) each year or ($5.70) on an earnings per share basis. Orthopediatrics employs 69 workers across the globe.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]


MarketBeat Community Rating for Orthopediatrics (KIDS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  123
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Orthopediatrics (NASDAQ:KIDS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Orthopediatrics in the last 12 months. Their average twelve-month price target is $23.6667, suggesting that the stock has a possible upside of 20.14%. The high price target for KIDS is $24.00 and the low price target for KIDS is $23.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $23.6667$23.6667$23.6667N/A
Price Target Upside: 20.14% upside18.04% upside18.04% upsideN/A

Orthopediatrics (NASDAQ:KIDS) Consensus Price Target History

Price Target History for Orthopediatrics (NASDAQ:KIDS)

Orthopediatrics (NASDAQ:KIDS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2018BTIG ResearchReiterated RatingBuy$24.00MediumView Rating Details
11/6/2017William BlairInitiated CoverageOutperform -> OutperformN/AView Rating Details
11/6/2017Stifel NicolausInitiated CoverageBuy -> Buy$23.00N/AView Rating Details
11/6/2017Piper JaffrayInitiated CoverageOverweight -> Overweight$24.00N/AView Rating Details
(Data available from 4/20/2016 forward)

Earnings

Orthopediatrics (NASDAQ:KIDS) Earnings History and Estimates Chart

Earnings by Quarter for Orthopediatrics (NASDAQ:KIDS)

Orthopediatrics (NASDAQ:KIDS) Earnings Estimates

2018 EPS Consensus Estimate: ($0.25)
2019 EPS Consensus Estimate: ($0.10)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.08)($0.08)($0.08)
Q2 20181($0.04)($0.04)($0.04)
Q3 20181($0.04)($0.04)($0.04)
Q4 20181($0.09)($0.09)($0.09)
Q1 20191($0.08)($0.08)($0.08)
Q2 20191($0.04)($0.04)($0.04)
Q3 20191$0.01$0.01$0.01
Q4 20191$0.01$0.01$0.01

Orthopediatrics (NASDAQ KIDS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/6/2018        
3/7/2018Q4 2017($0.13)($3.93)$11.45 million$11.68 millionViewN/AView Earnings Details
11/8/2017Q3 2017($0.12)($1.70)$12.13 million$12.38 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Orthopediatrics (NASDAQ:KIDS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Orthopediatrics (NASDAQ KIDS) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 32.34%
Insider Trading History for Orthopediatrics (NASDAQ:KIDS)
Institutional Ownership by Quarter for Orthopediatrics (NASDAQ:KIDS)

Orthopediatrics (NASDAQ KIDS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/13/2018Daniel J GerritzenGeneral CounselSell11,145$17.92$199,718.40View SEC Filing  
4/13/2018David R BaileyInsiderSell30,231$17.92$541,739.52View SEC Filing  
4/13/2018Fred HiteCFOSell29,471$17.92$528,120.32View SEC Filing  
3/12/2018David R PelizzonDirectorBuy1,000$17.50$17,500.00View SEC Filing  
10/16/2017Harold RufDirectorBuy11,500$13.00$149,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Orthopediatrics (NASDAQ KIDS) News Headlines

Source:
DateHeadline
Orthopediatrics (KIDS) Upgraded to "Hold" by BidaskClubOrthopediatrics (KIDS) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - April 19 at 9:58 AM
Orthopediatrics Corp (KIDS) Given Average Recommendation of "Hold" by AnalystsOrthopediatrics Corp (KIDS) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 19 at 3:26 AM
Insider Selling: Orthopediatrics Corp (KIDS) CFO Sells 29,471 Shares of StockInsider Selling: Orthopediatrics Corp (KIDS) CFO Sells 29,471 Shares of Stock
www.americanbankingnews.com - April 16 at 4:27 PM
Orthopediatrics Corp (KIDS) Insider Sells $541,739.52 in StockOrthopediatrics Corp (KIDS) Insider Sells $541,739.52 in Stock
www.americanbankingnews.com - April 16 at 4:27 PM
Orthopediatrics Corp (KIDS) General Counsel Sells $199,718.40 in StockOrthopediatrics Corp (KIDS) General Counsel Sells $199,718.40 in Stock
www.americanbankingnews.com - April 16 at 4:27 PM
OrthoPediatrics Corp. Honored as One of the Best Places to Work in Indiana for a Second YearOrthoPediatrics Corp. Honored as One of the Best Places to Work in Indiana for a Second Year
finance.yahoo.com - April 16 at 9:46 AM
 Analysts Anticipate Orthopediatrics Corp (KIDS) Will Announce Quarterly Sales of $11.38 Million Analysts Anticipate Orthopediatrics Corp (KIDS) Will Announce Quarterly Sales of $11.38 Million
www.americanbankingnews.com - April 13 at 5:01 AM
-$0.28 Earnings Per Share Expected for Orthopediatrics Corp (KIDS) This Quarter-$0.28 Earnings Per Share Expected for Orthopediatrics Corp (KIDS) This Quarter
www.americanbankingnews.com - April 11 at 1:08 AM
OrthoPediatrics Corp. Announces Sponsorship of 2018 EPOS Meeting and Lunch SymposiumOrthoPediatrics Corp. Announces Sponsorship of 2018 EPOS Meeting and Lunch Symposium
finance.yahoo.com - April 9 at 10:05 AM
Orthopediatrics Corps Lock-Up Period To End  on April 10th (NASDAQ:KIDS)Orthopediatrics Corp's Lock-Up Period To End on April 10th (NASDAQ:KIDS)
www.americanbankingnews.com - April 3 at 1:05 AM
Orthopediatrics (KIDS) Coverage Initiated at Piper JaffrayOrthopediatrics (KIDS) Coverage Initiated at Piper Jaffray
www.americanbankingnews.com - April 1 at 8:42 PM
Orthopediatrics (KIDS) Lowered to "Sell" at BidaskClubOrthopediatrics (KIDS) Lowered to "Sell" at BidaskClub
www.americanbankingnews.com - March 30 at 2:19 PM
Orthopediatrics (KIDS) Lowered to "Sell" at Zacks Investment ResearchOrthopediatrics (KIDS) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - March 30 at 1:28 PM
Orthopediatrics Corp (KIDS) Given Average Rating of "Hold" by BrokeragesOrthopediatrics Corp (KIDS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 25 at 3:12 AM
OrthoPediatrics Corp. Introduces PediFlex™ Advanced Surgical SystemOrthoPediatrics Corp. Introduces PediFlex™ Advanced Surgical System
finance.yahoo.com - March 23 at 9:44 AM
Zacks Investment Research Lowers Orthopediatrics (KIDS) to SellZacks Investment Research Lowers Orthopediatrics (KIDS) to Sell
www.americanbankingnews.com - March 18 at 11:16 AM
Orthopediatrics Corp (KIDS) Director David R. Pelizzon Purchases 1,000 SharesOrthopediatrics Corp (KIDS) Director David R. Pelizzon Purchases 1,000 Shares
www.americanbankingnews.com - March 13 at 8:52 PM
Brokers Set Expectations for Orthopediatrics Corps Q1 2019 Earnings (KIDS)Brokers Set Expectations for Orthopediatrics Corp's Q1 2019 Earnings (KIDS)
www.americanbankingnews.com - March 12 at 7:04 AM
Head-To-Head Contrast: Stryker (SYK) versus Orthopediatrics (KIDS)Head-To-Head Contrast: Stryker (SYK) versus Orthopediatrics (KIDS)
www.americanbankingnews.com - March 9 at 5:21 PM
OrthoPediatrics reports 4Q lossOrthoPediatrics reports 4Q loss
finance.yahoo.com - March 8 at 10:12 AM
Orthopediatrics (KIDS) Posts  Earnings ResultsOrthopediatrics (KIDS) Posts Earnings Results
www.americanbankingnews.com - March 7 at 8:56 PM
Orthopediatrics Corp (KIDS) Expected to Announce Earnings of -$0.13 Per ShareOrthopediatrics Corp (KIDS) Expected to Announce Earnings of -$0.13 Per Share
www.americanbankingnews.com - March 7 at 7:08 PM
OrthoPediatrics EPS of -$4.35OrthoPediatrics EPS of -$4.35
seekingalpha.com - March 7 at 4:57 PM
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2017 Financial ResultsOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 7 at 4:57 PM
Royce & Associates LP Purchases New Position in Orthopediatrics Corp (KIDS)Royce & Associates LP Purchases New Position in Orthopediatrics Corp (KIDS)
www.americanbankingnews.com - March 6 at 11:15 AM
459,418 Shares in Orthopediatrics Corp (KIDS) Acquired by AWM Investment Company Inc.459,418 Shares in Orthopediatrics Corp (KIDS) Acquired by AWM Investment Company Inc.
www.americanbankingnews.com - March 6 at 4:44 AM
Next Century Growth Investors LLC Purchases New Position in Orthopediatrics Corp (KIDS)Next Century Growth Investors LLC Purchases New Position in Orthopediatrics Corp (KIDS)
www.americanbankingnews.com - March 4 at 2:31 PM
Cortina Asset Management LLC Invests $2.48 Million in Orthopediatrics Corp (KIDS)Cortina Asset Management LLC Invests $2.48 Million in Orthopediatrics Corp (KIDS)
www.americanbankingnews.com - March 3 at 5:28 AM
Orthopediatrics (KIDS) Scheduled to Post Quarterly Earnings on WednesdayOrthopediatrics (KIDS) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - February 28 at 9:14 AM
Orthopediatrics Corp (KIDS) Receives Average Rating of "Hold" from BrokeragesOrthopediatrics Corp (KIDS) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - February 28 at 3:16 AM
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018
finance.yahoo.com - February 27 at 9:48 AM
 Analysts Anticipate Orthopediatrics Corp (KIDS) Will Post Quarterly Sales of $11.45 Million Analysts Anticipate Orthopediatrics Corp (KIDS) Will Post Quarterly Sales of $11.45 Million
www.americanbankingnews.com - February 21 at 11:18 AM
OrthoPediatrics Corp. to Participate in Canaccord Genuity’s Musculoskeletal ConferenceOrthoPediatrics Corp. to Participate in Canaccord Genuity’s Musculoskeletal Conference
finance.yahoo.com - February 20 at 9:20 AM
-$0.13 Earnings Per Share Expected for Orthopediatrics Corp (KIDS) This Quarter-$0.13 Earnings Per Share Expected for Orthopediatrics Corp (KIDS) This Quarter
www.americanbankingnews.com - February 19 at 3:18 AM
OrthoPediatrics Corp. to Participate in BTIG Healthcare ConferenceOrthoPediatrics Corp. to Participate in BTIG Healthcare Conference
finance.yahoo.com - February 13 at 4:40 PM
Orthopediatrics Corp (KIDS) Expected to Post Quarterly Sales of $11.45 MillionOrthopediatrics Corp (KIDS) Expected to Post Quarterly Sales of $11.45 Million
www.americanbankingnews.com - February 4 at 8:02 AM
Orthopediatrics Corp (KIDS) Given Average Recommendation of "Hold" by BrokeragesOrthopediatrics Corp (KIDS) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 3 at 5:46 AM
Zacks: Brokerages Anticipate Orthopediatrics Corp (KIDS) Will Post Earnings of -$0.13 Per ShareZacks: Brokerages Anticipate Orthopediatrics Corp (KIDS) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - February 2 at 3:12 AM
Reviewing St Jude Medical (STJ) and Orthopediatrics (KIDS)Reviewing St Jude Medical (STJ) and Orthopediatrics (KIDS)
www.americanbankingnews.com - January 12 at 1:18 AM
Orthopediatrics Corp (KIDS) Given Consensus Recommendation of "Hold" by BrokeragesOrthopediatrics Corp (KIDS) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 9 at 8:06 AM
Head-To-Head Contrast: Obalon Therapeutics (OBLN) versus Orthopediatrics (KIDS)Head-To-Head Contrast: Obalon Therapeutics (OBLN) versus Orthopediatrics (KIDS)
www.americanbankingnews.com - January 8 at 7:40 AM
Orthopediatrics (KIDS) Buy Rating Reaffirmed at BTIG ResearchOrthopediatrics' (KIDS) Buy Rating Reaffirmed at BTIG Research
www.americanbankingnews.com - January 6 at 9:56 AM
OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017
finance.yahoo.com - January 5 at 5:42 PM
OrthoPediatrics Corp. Expands PediPlates® Franchise with Titanium SystemOrthoPediatrics Corp. Expands PediPlates® Franchise with Titanium System
finance.yahoo.com - January 3 at 6:01 PM
 Analysts Set $23.67 Target Price for Orthopediatrics Corp (KIDS) Analysts Set $23.67 Target Price for Orthopediatrics Corp (KIDS)
www.americanbankingnews.com - January 2 at 8:02 AM
St Jude Medical (STJ) & Orthopediatrics (KIDS) Financial ComparisonSt Jude Medical (STJ) & Orthopediatrics (KIDS) Financial Comparison
www.americanbankingnews.com - December 31 at 11:14 PM
OrthoPediatrics Corp. :KIDS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017OrthoPediatrics Corp. :KIDS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 28 at 5:20 PM
ETFs with exposure to OrthoPediatrics Corp. : December 28, 2017ETFs with exposure to OrthoPediatrics Corp. : December 28, 2017
finance.yahoo.com - December 28 at 5:20 PM
Orthopediatrics (KIDS) & St Jude Medical (STJ) Critical ComparisonOrthopediatrics (KIDS) & St Jude Medical (STJ) Critical Comparison
www.americanbankingnews.com - December 17 at 7:26 PM
OrthoPediatrics Corp. Appoints Samuel D. Riccitelli to its Board of DirectorsOrthoPediatrics Corp. Appoints Samuel D. Riccitelli to its Board of Directors
finance.yahoo.com - December 15 at 9:04 AM

SEC Filings

Orthopediatrics (NASDAQ:KIDS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Orthopediatrics (NASDAQ:KIDS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Orthopediatrics (NASDAQ KIDS) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.